Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT00942682 · COMPLETED

Trial details

NCT number: NCT00942682
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumor Carcinoid Tumor Pancreatic Neuroendocrine Tumor

Start date: 2009-07-01
Primary completion: 2013-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.